NEW! Investment Companies Centre

American Express Platinum Cashback Card:

Sinclair Pharma (SPH)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE Fledgling

Market Cap

£16.38m

Change Today

Price Up0.25p (1.49%)

Share Price

17.00p

Sinclair Pharma Overview

Sinclair Pharma is in the pharmaceuticals & biotechnology sector and is currently trading at 17.00p per share. In the last year Sinclair Pharma's share price has ranged from 16.75p to 74.50p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (02-Dec-2008)

1 Day Chart

6 Month Chart

6 Month Chart

Income & Efficiency

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 7.3% n/a
ROCE 20.0%  

Valuation

Latest F'cast
P/E n/a 11.5
PEG n/a n/a
Pr/Revenue 0.5 0.5
Pr/Book 0.2  

Growth

Latest F'cast
Revenue 30.6% 8.4%
PBT n/a -100.0%
EPS n/a n/a
DPS n/a n/a

Sinclair Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-04 a2.65 a(2.72) (6.59)p n/a n/a n/a n/a 0.0%
30-Jun-05 6.97 (1.76) (3.70)p n/a n/a n/a n/a 0.0%
30-Jun-06 11.62 (2.75) (4.50)p n/a n/a n/a n/a 0.0%
30-Jun-07 23.18 (3.98) (3.20)p n/a n/a n/a n/a 0.0%
30-Jun-08 30.28 1.90 (1.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Sinclair Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-09 32.81 n/a 1.48p 11.5 n/a n/a n/a 0.0%

Covering analysts: AEK, Investec Securities, Teathers Limited

Sinclair Pharma Company Announcements

Total Voting Rights 28-Nov-2008 16:07 RNS
Annual Information Update 20-Nov-2008 07:00 PR Newswire
Additional Listing 18-Nov-2008 15:22 RNS

Latest Sinclair Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Sinclair Pharma Market Data

Currency UK Pounds
Share Price 17.00p Price Up
Change Today +0.25p
52 Week High 74.50
52 Week Low 16.75
Volume 18,700
Shares Issued 96.33m
Market Cap £16.38m
Beta 0.07
RiskGrade 503

Sinclair Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
9.77% above the market average9.77% above the market average9.77% above the market average9.77% above the market average9.77% above the market average
82.05% above the sector average82.05% above the sector average82.05% above the sector average82.05% above the sector average82.05% above the sector average
Price Trend
66.51% below the market average66.51% below the market average66.51% below the market average66.51% below the market average66.51% below the market average
56.82% below the sector average56.82% below the sector average56.82% below the sector average56.82% below the sector average56.82% below the sector average
Income Not Available
Growth
49.26% above the market average49.26% above the market average49.26% above the market average49.26% above the market average49.26% above the market average
40.85% above the sector average40.85% above the sector average40.85% above the sector average40.85% above the sector average40.85% above the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Sinclair Pharma Dividends

No dividends found

Trades for 02-Dec-2008

Time Volume / Share Price
16:35 10,000 @ 17.00p
14:42 8,700 @ 17.00p

Sinclair Pharma Key Personnel

CEO Michael Flynn
CFO Jerry Randall
COO Derek Williams
Finance Director Alan Olby

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).